Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Joseph

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Scientific Reports|July 23, 2025
Comparative analysis of cutaneous features of psoriasis in acute and chronic imiquimod-induced mouse modelsEmma Fraillon, Jean-François Jégou, Hanitriniaina Rabeony, et al.
The Journal of Prosthetic Dentistry|November 2, 2023
Gingival displacement before impression making: A prospective, comparative randomized clinical trialMarie Desclos-Theveniau, Hugo Abgrall, Vincent Bar, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
Molecular sequelae of proteasome inhibition in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
European Journal of Medicinal Chemistry|April 17, 2012
Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activityNicolas Masurier, Eric Debiton, Alicia Jacquemet, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survivalLuiz F Zerbini, Yihong Wang, Akos Czibere, et al.
Oncoimmunology|June 7, 2018
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancerMagalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, et al.
Cancer Research|December 21, 2006
A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cellsLuiz F Zerbini, Akos Czibere, Yihong Wang, et al.
Blood|November 9, 2002
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applicationsNicholas Mitsiades, Constantine S Mitsiades, Paul G Richardson, et al.
Cancer Cell|March 31, 2004
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumorsConstantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.
Oncotarget|April 22, 2017
Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic miceLaurie Rangan, Jeanne Galaine, Romain Boidot, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Scientific Reports|July 23, 2025
Comparative analysis of cutaneous features of psoriasis in acute and chronic imiquimod-induced mouse modelsEmma Fraillon, Jean-François Jégou, Hanitriniaina Rabeony, et al.
The Journal of Prosthetic Dentistry|November 2, 2023
Gingival displacement before impression making: A prospective, comparative randomized clinical trialMarie Desclos-Theveniau, Hugo Abgrall, Vincent Bar, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
Molecular sequelae of proteasome inhibition in human multiple myeloma cellsNicholas Mitsiades, Constantine S Mitsiades, Vassiliki Poulaki, et al.
European Journal of Medicinal Chemistry|April 17, 2012
Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activityNicolas Masurier, Eric Debiton, Alicia Jacquemet, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 9, 2004
NF-kappa B-mediated repression of growth arrest- and DNA-damage-inducible proteins 45alpha and gamma is essential for cancer cell survivalLuiz F Zerbini, Yihong Wang, Akos Czibere, et al.
Oncoimmunology|June 7, 2018
PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancerMagalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange, et al.
Cancer Research|December 21, 2006
A novel pathway involving melanoma differentiation associated gene-7/interleukin-24 mediates nonsteroidal anti-inflammatory drug-induced apoptosis and growth arrest of cancer cellsLuiz F Zerbini, Akos Czibere, Yihong Wang, et al.
Blood|November 9, 2002
The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applicationsNicholas Mitsiades, Constantine S Mitsiades, Paul G Richardson, et al.
Cancer Cell|March 31, 2004
Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumorsConstantine S Mitsiades, Nicholas S Mitsiades, Ciaran J McMullan, et al.
Oncotarget|April 22, 2017
Identification of a novel PD-L1 positive solid tumor transplantable in HLA-A*0201/DRB1*0101 transgenic miceLaurie Rangan, Jeanne Galaine, Romain Boidot, et al.
Pageof 6